Insider Trading activities of Eyegate Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eyegate Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eyegate Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Eyegate Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is EYEG. The reporting company's CIK number is 1372514.
The total value of stock buying since 2005 is $2,911,872.
The total value of stock sales since 2005 is $304,980.
The total value of stock option exercises since 2005 is $69,484.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Eyegate Pharmaceuticals Inc (EYEG).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 22,500 $22,875 0 $0 0 $0
2017-06 80,000 $0 0 $0 17,570 $11,420
2017-03 0 $0 13,338 $39,143 0 $0
2017-02 0 $0 0 $0 1,083 $1,841
2016-09 15,000 $22,335 0 $0 0 $0
2016-06 0 $0 83,939 $265,837 86,765 $56,223
2015-02 477,777 $2,866,662 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Eyegate Pharmaceuticals Inc insiders (EYEG)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-15 Romano Sarah (Interim CFO) Buy 10,000 1.00 10,000
2017-08-10 From Stephen (President and CEO) Buy 12,500 1.03 12,875
2017-06-14 Romano Sarah (Interim CFO) Buy 20,000 .00 0
2017-06-14 From Stephen (President and CEO) Buy 60,000 .00 0
2017-06-02 Chaney Paul G Option Ex 17,570 .65 11,420
2017-03-13 Ventech Capital Ii Sale 4,419 2.80 12,386
2017-03-06 Goldberg Morton Sale 8,919 3.00 26,757
2017-02-27 Goldberg Morton Option Ex 1,083 1.70 1,841
2016-09-15 From Stephen (President and CEO) Buy 15,000 1.49 22,335
2016-06-30 From Stephen (President and CEO) Option Ex 52,990 .65 34,337
2016-06-15 Goldberg Morton Sale 15,000 3.16 47,355
2016-06-10 Ventech Capital Ii Sale 15,433 3.00 46,329
2016-06-09 Ventech Capital Ii Sale 13,167 3.08 40,528
2016-06-08 Ventech Capital Ii Sale 2,400 3.20 7,680
2016-06-07 Goldberg Morton Sale 746 3.31 2,472
2016-06-07 Ventech Capital Ii Sale 17,000 3.24 55,063
2016-06-06 Goldberg Morton Sale 5,543 3.25 18,042
2016-06-06 Ventech Capital Ii Sale 10,000 3.27 32,679
2016-06-03 Goldberg Morton Sale 4,650 3.37 15,689
2016-06-03 Goldberg Morton Option Ex 33,775 .65 21,886
2015-02-19 Ipsa (innoven Partenaires S.a.) Buy 366,667 6.00 2,200,002
2015-02-19 Ventech Capital Ii Buy 102,777 6.00 616,662
2015-02-19 Chaney Paul G Buy 8,333 6.00 49,998

Insider trading activities including stock purchases, stock sales, and option exercises of EYEG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eyegate Pharmaceuticals Inc (symbol EYEG, CIK number 1372514) see the Securities and Exchange Commission (SEC) website.